Wikidata

(Q39365419)

English

Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease

scientific article

In more languages

Statements

title
Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15975564
retrieved
11 September 2017
author name string
Paolo Urbani
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15975564
retrieved
11 September 2017
José Antonio Ramos
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15975564
retrieved
11 September 2017
Javier Fernández-Ruiz
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15975564
retrieved
11 September 2017
publication date
1 July 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15975564
retrieved
11 September 2017
volume
1050
1 reference
stated in
Europe PubMed Central
PubMed ID
15975564
retrieved
11 September 2017
page(s)
210-216
1 reference
stated in
Europe PubMed Central
PubMed ID
15975564
retrieved
11 September 2017
issue
1-2
1 reference
stated in
Europe PubMed Central
PubMed ID
15975564
retrieved
11 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39365419&oldid=1823076836"